SKYE
Skye Bioscience, Inc.
1.80$
+5.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.5% | -2.9% | +8.1% | +121.5% | +165.6% | +1.2% | +5.5% | -4.4% | -99,051.1% | – | -8.8% | – | |
| – | +270.1% | +318.0% | -26.2% | +5.1% | +8.7% | +5.4% | -7.7% | -5.9% | -114,934.5% | – | -15.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -180.3% | – | – | -155.0% | – | -25.6% | -177.7% | – | |
| – | +90.9% | -54.6% | +920.5% | +4,577.2% | -96.7% | +12,517.9% | -100.0% | +66.7% | -40.0% | +0.0% | -100.0% | – | |
| – | -100.7% | – | -102.8% | +4,352.8% | – | -14,167,738.5% | -99.9% | – | -135.2% | – | -34.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +50.0% | – | |
| – | -100.1% | – | -102.4% | -100.0% | – | -100.0% | – | -100.0% | – | -726.7% | +41.2% | – | |
| – | -128.4% | – | -111.2% | – | – | – | – | – | – | – | -103.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.